Work

A Phase 2 Trial of the Multitargeted Kinase Inhibitor Lenvatinib (E7080) in Patients (PTS) with Recurrent Glioblastoma (GBM) And Disease Progression Following Prior Bevacizumab Treatment

Year: 2012

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)33001-5

Authors: D.A. Reardon, E. Pan, J. Fan, J. Mink, D.P. Barboriak, J.J. Vredenburgh, A. Desjardins, K. Peters, J.P. O'Brien, P.Y. Wen

Institutions: Dana-Farber Cancer Institute, Moffitt Cancer Center, Eisai (United States), Duke Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2999522369

FWCI:

Cites:

Cited by: 8

Related to: 10